Literature DB >> 25209331

Compound heterozygous PLEC mutations in a patient of consanguineous parentage with epidermolysis bullosa simplex with muscular dystrophy and diffuse alopecia.

Jinghua Yin1, Yali Ren, Zhimiao Lin, Huijun Wang, Yun Zhou, Yong Yang.   

Abstract

Epidermolysis bullosa simplex with muscular dystrophy (EBS-MD; OMIM 226670) is an autosomal recessive form of EBS, characterized by skin blistering at birth and delayed onset of muscle dystrophy. Mutations in PLEC, the gene encoding plectin, have been identified to be causal for EBS-MD. We report a case of EBS-MD with diffuse alopecia. Genetic study revealed the patient carrying compound heterozygous mutations in PLEC despite the consanguineous parentage.
© 2014 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25209331     DOI: 10.1111/ijd.12655

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  4 in total

Review 1.  Epidermolysis bullosa simplex with muscular dystrophy. Review of the literature and a case report.

Authors:  Jana Kyrova; Lenka Kopeckova; Hana Buckova; Lenka Mrazova; Karel Vesely; Marketa Hermanova; Hana Oslejskova; Lenka Fajkusova
Journal:  J Dermatol Case Rep       Date:  2016-11-30

2.  Epidermolysis bullosa simplex with muscular dystrophy associated with PLEC deletion mutation.

Authors:  Valeria Carolina Alvarez; Sini Tellervo Penttilä; Valeria Luján Salutto; Bjarne Udd; Claudio Gabriel Mazia
Journal:  Neurol Genet       Date:  2016-10-11

3.  A novel PLEC nonsense homozygous mutation (c.7159G > T; p.Glu2387*) causes epidermolysis bullosa simplex with muscular dystrophy and diffuse alopecia: a case report.

Authors:  Zoe Argyropoulou; Lu Liu; Linda Ozoemena; Claudia C Branco; Raquel Senra; Ângela Reis-Rego; Luisa Mota-Vieira
Journal:  BMC Dermatol       Date:  2018-01-20

Review 4.  Plectin in Skin Fragility Disorders.

Authors:  Dimitra Kiritsi; Leonidas Tsakiris; Franziska Schauer
Journal:  Cells       Date:  2021-10-14       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.